Publicaciones en colaboración con investigadores/as de City Hospital (23)

2013

  1. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting

    Age and Ageing, Vol. 42, Núm. 1, pp. 70-75

2011

  1. Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: A pilot study

    Thrombosis Research

2010

  1. Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease

    International Journal of Cardiology, Vol. 139, Núm. 1, pp. 95-97

  2. The prognostic value of biomarkers after a premature myocardial infarction

    International Journal of Cardiology, Vol. 143, Núm. 3, pp. 249-254

2009

  1. Biomarkers of pathophysiology in hypertrophic cardiomyopathy: Implications for clinical management and prognosis

    European Heart Journal, Vol. 30, Núm. 2, pp. 139-151

  2. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation

    European Heart Journal, Vol. 30, Núm. 8, pp. 932-939

  3. Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation

    International Journal of Cardiology, Vol. 132, Núm. 2, pp. 227-232

2008

  1. Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

    Annals of Medicine, Vol. 40, Núm. 7, pp. 553-559

  2. The impact of statin use on atrial fibrillation

    QJM, Vol. 101, Núm. 11, pp. 845-861

2007

  1. Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromes

    Cerebrovascular Diseases, Vol. 24, Núm. 4, pp. 338-342

  2. Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: Relation to functional data and prognosis

    Journal of Internal Medicine, Vol. 262, Núm. 3, pp. 385-392

  3. Plasma angiogenin levels in acute coronary syndromes: Implications for prognosis

    European Heart Journal, Vol. 28, Núm. 24, pp. 3006-3011

2006

  1. Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?

    International Journal of Cardiology, Vol. 110, Núm. 2, pp. 265-266

2005

  1. Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain

    International Journal of Cardiology, Vol. 100, Núm. 1, pp. 151-154

  2. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation

    Thrombosis Research, Vol. 116, Núm. 4, pp. 321-325

2004

  1. Matrix Metalloproteinases in Atrial Fibrillation [2] (multiple letters)

    Journal of the American College of Cardiology

  2. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation

    Heart, Vol. 90, Núm. 10, pp. 1162-1166

  3. Soluble E-selectin, interleukin-6 and tissue factor in two cases of meningococcal septicaemia

    Blood Coagulation and Fibrinolysis, Vol. 15, Núm. 2, pp. 179-182

2003

  1. Fibrinolytic function and atrial fibrillation

    Thrombosis Research, Vol. 109, Núm. 5-6, pp. 233-240

  2. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation

    European Heart Journal, Vol. 24, Núm. 14, pp. 1373-1380